After moving to Stanford in 2016, Huberman discovered and published[23] the use of non-invasive methods such as visual stimulation can enhance regeneration of damaged retinal neurons, leading to partial recovery from blindness, especially when the stimulation is paired with specific forms of gene therapy. The work was covered extensively in the popular press, including Time magazine and Scientific American and is part of the National Eye Institute's Audacious Goals Initiative to restore vision to the blind. The Huberman Lab extended those findings to develop a human clinical trial using virtual reality technology to stimulate regeneration and plasticity of damaged retinal and other visual system neurons.[citation needed]